StockData
Cardinal Health Inc logo

Cardinal Health Inc

CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3040% above fair value
$272.81+0.47 (+0.17%)

Close on Nov 20, 2026Market cap $63.45BP/E 37.7Yield 0.75%

Cardinal Health OptumRx — Share of Consolidated Revenue by Year

OptumRx — Share of Consolidated Revenue (%) (%)

Periods

Cardinal Health OptumRx — Share of Consolidated Revenue: 0.0% in FY2026, unchanged from a year earlier.

Latest, FY2026
0.0%
Period ended Jun 30, 2026 (CY2026)
Change on a year earlier
0.0 pts
0.0% in FY2025
History
6 years
Since FY2021
Sources
4
Documents cited below

Where the FY2026 figure comes from

Source: CAH SEC Form 10-K (filed 2026-08-11) ↗

0% in FY2025–FY2026 following expiration of OptumRx pharmaceutical distribution contracts in June 2024 (17% in FY2024).

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOptumRx — Share of Consolidated Revenue (%) (%)Year on yearSource
FY2026CY2026Jun 30, 20260.0%0.0 ptsCAH SEC Form 10-K (filed 2026-08-11) ↗
FY2025CY2025Jun 30, 20250.0%-17.0 ptsCAH SEC Form 10-K (filed 2026-08-11) ↗
FY2024CY2024Jun 30, 202417.0%+1.0 ptsCAH SEC Form 10-K (filed 2024-08-14) ↗
FY2023CY2023Jun 30, 202316.0%0.0 ptsCAH SEC Form 10-K (filed 2023-08-15) ↗
FY2022CY2022Jun 30, 202216.0%+1.0 ptsCAH SEC Form 10-K (filed 2022-08-11) ↗
FY2021CY2021Jun 30, 202115.0%–CAH SEC Form 10-K (filed 2023-08-15) ↗

Cite this data

StockData. (2026). Cardinal Health OptumRx — Share of Consolidated Revenue (%), annual FY2021–FY2026 [Data set]. Compiled from Cardinal Health SEC filings and investor materials. https://stockdatahq.com/stocks/cah/kpis/conc-optum-rev

See every metric in the Cardinal Health KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?